ICCM logo

ICECURE MEDICAL LTD

ICCMNASDAQ
πŸ† #5092 by market capEarnings Nov 2US Equity
β€”β€”
Quote unavailable
πŸ””
Track ICCM
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$4M
Small Cap
πŸ“ˆRevenue Growth (YoY)
41.6%
High Growth
πŸ“ŠGross Margin
36.1%
Healthy
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
0.9x
Cheap
Otter Score
β€”
Insufficient data
No chart data available for ICCM.

Trading Snapshot

Day Range
β€”
52-Week Range
$0.96 – $24.90
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
3.4M
Next Earnings
2026-11-02

Fundamentals Snapshot

Annual Revenue
$3M
Last Q Revenue
$907,000
P/E Ratio
β€”
P/S Ratio
0.9x
EPS (TTM)
$-6.73
Dividend Yield
β€”
Dilution (1yr)
+31.0%
ICCM logo

ICECURE MEDICAL LTD

ICCM
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3Mβ–² +2.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
36.3%β–Ό βˆ’17.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$15Mβ–Ό βˆ’3.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$15Mβ–² +15.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
2.4Mβ–² +31.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$9Mβ–² +$2M YoY
StockOtter Β· stockotter.space

About ICECURE MEDICAL LTD

IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets. The company is headquartered in Caesarea, Israel.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.